People · Operator

Brian Chirico

Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology

1
Companies
1
Filings
$28.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Tangen Biosciences, Inc.BiotechnologySeries A$28.4M$4.2M2020
Operator network

Brian Chirico at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Dan Wagner · 4 companies · 1 sharedDan WagnerChristopher Benoit · 3 companies · 1 sharedChristopher BenoitChristopher McLeod · 3 companies · 1 sharedChristopher McLeodDaniel V. Wagner · 2 companies · 1 sharedDaniel V. WagnerJohn Davidson · 2 companies · 1 sharedJohn DavidsonAlan V. Levin · 1 companies · 1 sharedAlan V. LevinChristopher V. McLeod · 1 companies · 1 sharedChristopher V. Mc…John Nobile · 1 companies · 1 sharedJohn NobileJohn Richard Davidson · 1 companies · 1 sharedJohn Richard Davi…John Richard Nobile · 1 companies · 1 sharedJohn Richard Nobi…John V. Davidson · 1 companies · 1 sharedJohn V. DavidsonRichard Birkmeyer, PhD · 1 companies · 1 sharedRichard Birkmeyer…Richard C. Birkmeyer, PhD · 1 companies · 1 sharedRichard C. Birkme…Vance V. Kershner · 1 companies · 1 sharedVance V. KershnerTangen Biosciences, Inc. · $28.4M raisedTangen Biosciences, I…Brian ChiricoBC
Brian Chirico Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Brian Chirico on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Dan Wagner14
Christopher McLeod13
Christopher Benoit13
Daniel V. Wagner12
John Davidson12
Vance V. Kershner11
Christopher V. McLeod11
John V. Davidson11
Richard Birkmeyer, PhD11
John Nobile11
John Richard Nobile11
John Richard Davidson11
Alan V. Levin11
Richard C. Birkmeyer, PhD11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.